Fenofibrate/insulin | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.11.2022 | Case report

Fenofibrate/insulin

Liver injury and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Anzeige

Waksman O, et al. Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure. JACC: Case Reports 4: 1348-1352, No. 20, 19 Oct 2022. Available from: URL: http://doi.org/10.1016/j.jaccas.2022.09.001

Titel: Fenofibrate/insulin
Liver injury and lack of efficacy: case report
Publikationsdatum: 01.11.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-27647-y